Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Neurological complications of BD (neuro-Behçet's disease [NBD]) are life-threatening and disabling manifestations. Neurological involvement occurs in approximately 5% to 18% of patients with BD. Most patients with NBD respond well to glucocorticoids, cyclophosphamide, or anti-tumor necrosis fac...

Descripción completa

Detalles Bibliográficos
Autor principal: Karabulut, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Literature Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176236/
https://www.ncbi.nlm.nih.gov/pubmed/34554909
http://dx.doi.org/10.5152/eurjrheum.2021.20160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176236/
https://www.ncbi.nlm.nih.gov/pubmed/34554909
http://dx.doi.org/10.5152/eurjrheum.2021.20160

Ejemplares similares